IL117115A - Process for preparing recombinant adenovirus genomes - Google Patents

Process for preparing recombinant adenovirus genomes

Info

Publication number
IL117115A
IL117115A IL11711596A IL11711596A IL117115A IL 117115 A IL117115 A IL 117115A IL 11711596 A IL11711596 A IL 11711596A IL 11711596 A IL11711596 A IL 11711596A IL 117115 A IL117115 A IL 117115A
Authority
IL
Israel
Prior art keywords
recombinant adenovirus
preparing recombinant
adenovirus genomes
adenoviruses
genomes
Prior art date
Application number
IL11711596A
Other languages
English (en)
Other versions
IL117115A0 (en
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9476085&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL117115(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of IL117115A0 publication Critical patent/IL117115A0/xx
Publication of IL117115A publication Critical patent/IL117115A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10351—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Plant Pathology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
IL11711596A 1995-02-13 1996-02-12 Process for preparing recombinant adenovirus genomes IL117115A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9501632A FR2730504B1 (fr) 1995-02-13 1995-02-13 Procede de preparation de genomes d'adenovirus recombinants

Publications (2)

Publication Number Publication Date
IL117115A0 IL117115A0 (en) 1996-06-18
IL117115A true IL117115A (en) 2005-06-19

Family

ID=9476085

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11711596A IL117115A (en) 1995-02-13 1996-02-12 Process for preparing recombinant adenovirus genomes

Country Status (19)

Country Link
US (1) US6261807B1 (es)
EP (1) EP0809704B1 (es)
JP (1) JP3842818B2 (es)
KR (1) KR100575521B1 (es)
AT (1) ATE405662T1 (es)
AU (1) AU716777B2 (es)
BR (1) BRPI9607583B8 (es)
CA (1) CA2210956C (es)
CZ (1) CZ294338B6 (es)
DE (1) DE69637648D1 (es)
FI (1) FI120046B (es)
FR (1) FR2730504B1 (es)
HU (1) HU222808B1 (es)
IL (1) IL117115A (es)
MX (1) MX9705937A (es)
NO (1) NO327980B1 (es)
SK (1) SK286965B6 (es)
WO (1) WO1996025506A1 (es)
ZA (1) ZA961153B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020136708A1 (en) * 1993-06-24 2002-09-26 Graham Frank L. System for production of helper dependent adenovirus vectors based on use of endonucleases
DE19620687A1 (de) * 1996-05-22 1997-11-27 Centeon Pharma Gmbh Neuer adenoviraler Vektor für den Transfer humaner Gene in vivo
ATE256196T1 (de) 1997-06-09 2003-12-15 Genvec Inc Chimäre vektoren, die die verpackungsregion eines phagengenoms und einen teil des genoms eines eukaryontischen virus enthalten
WO1999015686A1 (en) * 1997-09-23 1999-04-01 Genvec, Inc. Plasmids for construction of eukaryotic viral vectors
CN1342206A (zh) * 1998-08-28 2002-03-27 杜克大学 在IVa2,100K和/或preterminal protein序列上有缺失的腺病毒
JP2004501602A (ja) * 1999-02-18 2004-01-22 メルク　アンド　カンパニー　インコーポレイテッド エンドヌクレアーゼの使用に基づくヘルパー依存アデノウイルスベクターの生産のためのシステム
FR2794771B1 (fr) 1999-06-11 2001-08-10 Aventis Pharma Sa Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)
FR2799472B1 (fr) 1999-10-07 2004-07-16 Aventis Pharma Sa Preparation d'adenovirus recombinants et de banques adenovirales
US6998263B2 (en) 2000-02-09 2006-02-14 Genvec, Inc. Methods of preparing and using a viral vector library
US7198924B2 (en) 2000-12-11 2007-04-03 Invitrogen Corporation Methods and compositions for synthesis of nucleic acid molecules using multiple recognition sites
US6573092B1 (en) 2000-10-10 2003-06-03 Genvec, Inc. Method of preparing a eukaryotic viral vector
AUPR518501A0 (en) 2001-05-22 2001-06-14 Unisearch Limited Yin yang-1
EP1453536A4 (en) 2001-12-12 2009-08-26 Mayne Pharma Int Pty Ltd COMPOSITION FOR PRESERVING VIRUSES
EP1697534B1 (en) 2003-12-01 2010-06-02 Life Technologies Corporation Nucleic acid molecules containing recombination sites and methods of using the same
DK2002003T3 (en) 2005-05-27 2016-03-21 Ospedale San Raffaele Srl Gene vector comprising miRNA
EP2147105B1 (en) 2007-05-02 2013-04-24 Merial Limited Dna plasmids having improved expression and stability
US20110269119A1 (en) * 2009-10-30 2011-11-03 Synthetic Genomics, Inc. Encoding text into nucleic acid sequences
AU2014338864C1 (en) * 2013-10-25 2020-07-16 Akamis Bio Limited Oncolytic adenoviruses armed with heterologous genes
US10076562B2 (en) 2016-04-19 2018-09-18 The Board Of Regents Of The University Of Texas System Methods for treating plague
WO2018054822A1 (en) 2016-09-20 2018-03-29 Boehringer Ingelheim Vetmedica Gmbh New swine influenza vaccine
NZ751966A (en) 2016-09-20 2023-03-31 Boehringer Ingelheim Vetmedica Gmbh New promoters
TWI817933B (zh) 2016-09-20 2023-10-11 德商百靈佳殷格翰維美迪加股份有限公司 新穎ehv***位點orf70
TW201823467A (zh) 2016-09-20 2018-07-01 德商百靈佳殷格翰維美迪加股份有限公司 犬腺病毒載體

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3532566B2 (ja) * 1993-06-24 2004-05-31 エル． グラハム，フランク 遺伝子治療のためのアデノウイルスベクター
SK282843B6 (sk) * 1993-07-13 2002-12-03 Rhone-Poulenc Rorer S. A. Defektný rekombinantný adenovírus a farmaceutický prostriedok s jeho obsahom
WO1995003400A1 (en) * 1993-07-23 1995-02-02 Johns Hopkins University School Of Medicine Recombinationally targeted cloning in yeast artificial chromosomes
FR2726285B1 (fr) * 1994-10-28 1996-11-29 Centre Nat Rech Scient Adenovirus depourvus de particules contaminantes viables, preparation et utilisation
DK0787200T3 (da) * 1994-10-28 2005-08-15 Univ Pennsylvania Forbedret adenovirus og fremgangsmåder til anvendelse heraf
FR2727689A1 (fr) * 1994-12-01 1996-06-07 Transgene Sa Nouveau procede de preparation d'un vecteur viral

Also Published As

Publication number Publication date
SK110097A3 (en) 1998-06-03
CA2210956C (fr) 2010-06-08
IL117115A0 (en) 1996-06-18
FI120046B (fi) 2009-06-15
JP3842818B2 (ja) 2006-11-08
MX9705937A (es) 1997-10-31
JPH11500007A (ja) 1999-01-06
CA2210956A1 (fr) 1996-08-22
AU716777B2 (en) 2000-03-09
NO327980B1 (no) 2009-11-02
NO973663L (no) 1997-08-08
BRPI9607583B8 (pt) 2016-11-08
BR9607583B1 (pt) 2009-12-01
HUP9800260A3 (en) 2000-12-28
HU222808B1 (hu) 2003-10-28
US6261807B1 (en) 2001-07-17
SK286965B6 (sk) 2009-08-06
AU4723596A (en) 1996-09-04
FI973309A (fi) 1997-08-12
CZ294338B6 (cs) 2004-12-15
KR19980702139A (ko) 1998-07-15
FR2730504A1 (fr) 1996-08-14
WO1996025506A1 (fr) 1996-08-22
NO973663D0 (no) 1997-08-08
BR9607583A (pt) 1998-07-07
HUP9800260A1 (hu) 1998-05-28
ATE405662T1 (de) 2008-09-15
EP0809704B1 (fr) 2008-08-20
KR100575521B1 (ko) 2006-10-24
CZ255497A3 (en) 1997-11-12
ZA961153B (en) 1996-08-23
DE69637648D1 (de) 2008-10-02
FR2730504B1 (fr) 1997-03-28
EP0809704A1 (fr) 1997-12-03
FI973309A0 (fi) 1997-08-12

Similar Documents

Publication Publication Date Title
ZA961153B (en) Process for preparing recombinant adenovirus genomes
CA2213343A1 (en) Chimeric adenoviral fiber protein and methods of using same
AU7264694A (en) Defective adenovirus vectors and use thereof in gene therapy
AU8147294A (en) Recombinant viruses coding for thymidine kinase in gene therapy
AU5723696A (en) Gene therapy using replication competent targeted adenoviral vectors
HUP9801207A3 (en) Therapeutic compositions for transfecting nucleic acids and use thereof
AU641568B2 (en) Polypeptide,DNA fragment encoding the same and process for producing the same, and enzyme inhibition process, drug composition and methods of treating using the same
AU8147194A (en) Recombinant adenoviruses for gene therapy in cancers
ZA956849B (en) Use of a defective recombinant adenovirus in gene therapy
AU6144494A (en) Recombinant adenoviruses and use thereof in gene therapy for treating eye diseases
AU7237391A (en) Carrier-bound recombinant protein, process for producing it and its use as an immunogen and vaccine
AU3866197A (en) Novel DNA and process for preparing protein using the DNA
HUP9902150A3 (en) Recombinant adenoviral vectors for human tumour gene therapy
ZA958128B (en) Viral vectors and use in gene therapy
AU7665396A (en) Recombinant viruses containing mobile genetic elements and methods of use in gene therapy
IL112993A0 (en) Recombinant niruses, their preparation and their use in gene therapy
AU6446190A (en) Process for inducing analgesia, peptides and therapeutic compositions
AU2620595A (en) Recombinant viruses, preparation and use thereof in gene therapy
AU1209797A (en) Novel antigenic proteins of mycoplasmata, genes thereof, and recombinant vector and use of the same
GB9604714D0 (en) Recombinant bovine adenovirus vector system and its application in gene therapy and in the development of recombinant vaccine
SI0889969T1 (sl) Rekombinantni adenovirusni vektorji za gensko terapijo humanih tumorjev
AU588996B2 (en) N-(2'-aminophenyl)-benzamine-derivatives, process for their preparation and their use in the control of neoplastic diseases
ZA951451B (en) Host vector system for use in gene therapy
AU5259896A (en) Recombinant rna viral vector and method of preparing the same

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired